Efficacy, Tolerability, & Safety of DFN-15

See also
Status	Clinical Trial	Phase
Completed	`NCT04084314` - Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study	Phase 4
Not yet recruiting	`NCT05943457` - Vitamin K2 Supplementation in Adult Episodic Migraine	N/A
Completed	`NCT01211145` - Zomig - Treatment of Acute Migraine Headache in Adolescents	Phase 4
Completed	`NCT00530517` - A Study on the Usability of the Needle-free Intraject® System in Adult Patients During Acute Migraine Attack	Phase 2
Completed	`NCT00898677` - Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030)	Phase 3
Recruiting	`NCT06459635` - Migraine Attack Pain Phase Prediction Study
Completed	`NCT03971071` - A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache	Phase 4
Withdrawn	`NCT02706015` - Cefaliv® Compared to Neosaldina® in the Treatment of Migraine Attacks	Phase 3
Completed	`NCT02518464` - Ticagrelor Therapy for RefrACTORy Migraine Study	Phase 4
Terminated	`NCT02375789` - Intranasal Cooling for Symptomatic Relief of Migraine	N/A
Terminated	`NCT00391755` - A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches	Phase 4
Completed	`NCT03401346` - Bioavailability of DHE Administered by I123 POD Device, IV Injection, and Migranal Nasal Spray in Healthy Adults	Phase 1
Completed	`NCT05085483` - Ketone for Migraine Prevention	N/A
Completed	`NCT01604785` - Low-dose Propofol for Pediatric Migraine	Phase 2/Phase 3
Terminated	`NCT00804973` - Study in Participants With Acute Migraines Headaches	Phase 2
Completed	`NCT03341689` - Psilocybin for the Treatment of Migraine Headache	Phase 1
Completed	`NCT01630044` - Neurostimulation Device for Treatment of Migraine Headache	N/A
Active, not recruiting	`NCT00285402` - Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine	Phase 2
Completed	`NCT00203255` - Clinical Study Examining Use of an Over-the-Counter Supplement for the Prevention of Menstrually-Associated Migraine Headache	N/A
Recruiting	`NCT06046508` - Migraine With Aura and Patent Foramen Ovale: Identification of Biomarkers to Select Patients In Whom Intervention Would Be Beneficial (MANET)

NCT number	NCT03009019
Study type	Interventional
Source	BioDelivery Sciences International
Contact
Status	Completed
Phase	Phase 3
Start date	December 2016
Completion date	May 2019

Efficacy, Tolerability, and Safety of DFN-15

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms